Provision of long-acting reversible contraception in HIV-prevalent countries: Results from nationally representative surveys in southern Africa

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 11, 2013, Pages 1386-1394

  Morse, J ^a   Chipato, T ^b   Blanchard, K ^c   Nhemachena, T ^d   Ramjee, G ^e   McCulloch, C ^f   Blum, M ^g   Saleeby, E ^f   Harper, C C ^g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UZ UCSF Collaborative Program in Women's Health   (Zimbabwe)

^c IBIS REPRODUCTIVE HEALTH   (United States)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; implantable contraception; intrauterine device; long acting reversible contraception; South Africa; Zimbabwe

Indexed keywords

COPPER INTRAUTERINE DEVICE; CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL COMPETENCE; CLINICAL PRACTICE; CONTRACEPTION; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LONG ACTING REVERSIBLE CONTRACEPTION; MAJOR CLINICAL STUDY; MALE; NURSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RURAL AREA; SOUTH AFRICA; URBAN AREA; ZIMBABWE; AFRICA SOUTH OF THE SAHARA; CESAREAN SECTION; CONDOM; COUNSELING; FAMILY PLANNING; HEALTH CARE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SURVEY; INFLUENZA VACCINATION; INSTRUMENT STERILIZATION; MULTIPARA; NOTE; PAPANICOLAOU TEST; POPULATION GROWTH; PREGNANCY; SCAR; UTERUS; VAGINAL DELIVERY; VASECTOMY;

EID: 84883876882     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.12290     Document Type: Article

References (19)

1. Sedgh G, Jussain R, Bankole A, Singh S,. Women with an unmet need for contraception in developing countries and their reasons for not using a method. Occasional Report No. 37. New York: Guttmacher Institute; 2007.
2. Chiou CF, Trussell J, Reyes E, Knight K, Wallace J, Udani J, et al. Economic analysis of contraceptives for women. Contraception 2003; 68: 3-10.
3. World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use, 4th edn. Geneva: World Health Organization, 2010.
4. Rochat TJ, Richter LM, Doll HA, Buthelezi NP, Tomkins A, Stein A,. Depression among pregnant rural South African women undergoing HIV testing. JAMA 2006; 295: 1376-8.
5. Reynolds HW, Janowitz B, Wilcher R, Cates W,. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries. Sex Transm Infect 2008; 84 (Suppl 2): 49-53.
6. Faculty of Family Planning Clinical Health Care Effectiveness Unit. The copper intrauterine device as long term contraception. J Fam Plann Reprod Health Care 2004; 30: 29-42.
7. Faculty of Family Planning Clinical Health Care Effectiveness Unit. The levonorgestrel-releasing intrauterine system in reproductive health contraception. J Fam Plann Reprod Health Care 2004; 30: 99-109.
8. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010; Adapted from the World Health Organization Medical Eligibility Criteria for Contraceptive Use, 4th edn. MMWR Early Release 2010;59:May 28.
9. Berwick DM,. Disseminating innovations in health care. JAMA 2003; 289: 1969-75.
10. Harper C, Holt K, Nhemachena T, Chipato T, Ramjee G, Stratton L, et al. Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa. AIDS Behav 2012; 7: 1821-9.
11. Sheldon WR, Nhemachena T, Blanchard K, Chipato T, Ramjee G, Trussell J, et al. Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis 2012; 39: 567-75.
12. Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M,. Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA 2000; 283: 1715-22.
13. Harper CC, Blum M, de Bocanegra HT, Darney PD, Speidel JJ, Policar M, et al. Challenges in translating evidence to practice: the provision of intrauterine contraception. Obstet Gynecol 2008; 111: 1359-69.
14. Harper CC, Henderson JT, Raine TR, Goodman S, Darney PD, Thompson KM, et al. Evidence-based IUD practice: family physicians and obstetrician- gynecologists. Fam Med 2012; 44: 564-72.
15. Curtis KM, Nanda K, Kapp N,. Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS 2009; 23 (Suppl 1): S55-67.
16. Stanwood NL, Garrett JM, Konrad TR,. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002; 99: 275-80.
17. Postlethwaite D, Shaber R, Mancuso V, Flores J, Armstrong M,. Intrauterine contraception: evaluation of clinician practice patterns in Kaiser Permanente Northern California. Contraception 2007; 75: 177-84.
18. Osei I, Birungi H, Addico G, Askew I, Gyapong JO,. What happened to the IUD in Ghana? Afr J Reprod Health 2005; 9: 76-91.
19. Aziz FA, Osman AA,. Safety of intrauterine device insertion by trained nurse-midwives in the Sudan. Adv Contracept 1999; 15: 9-14.